Status:
ENROLLING_BY_INVITATION
Pediatric Apple Watch Study
Lead Sponsor:
Stanford University
Conditions:
Arrhythmia in Children
Eligibility:
All Genders
6-21 years
Phase:
NA
Brief Summary
Specific Aim #1 - To determine the accuracy of Apple Watch ECG tracings heart rate in children. Specific Aim #2 - To determine if extended monitoring with the Apple Watch can identify arrhythmia even...
Eligibility Criteria
Inclusion
- All pediatric patients age 6 - 21 years undergoing clinically indicated arrhythmia monitoring
- Patients with developmental ability (as determined by patient and parents) to safely wear the Apple Watch and utilize the patient activated trigger buttons on both the clinical monitor and the Apple Watch.
Exclusion
- Age \< 6 years. Those under 6 many not be able to safely use the watch and have the developmental ability (as gauged by clinician and parents) to utilize the trigger features on the watch and cardiac rhythm monitor.
- Inability to effectively utilize the triggered features of the monitor or watch
- Patients unable to utilize the Apple Watch.
Key Trial Info
Start Date :
August 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06053372
Start Date
August 16 2024
End Date
March 1 2026
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94306